ATAGI shifts Covid vaccine preference

Monovalent Omicron XBB.1.5 Covid-19 vaccines are now the Australian Technical Advisory Group on Immunisation’s (ATAGI’s) preferred option for individuals aged five years and older   ATAGI has updated its guidance regarding the use of Covid-19 vaccinations to boost protection against Omicron subvariants of the XBB.1 and BA.2.8 sub-lineages, which are currently circulating in Australia.   The